Clinical Trials Directory

Trials / Conditions / Bipolar II Disorder

Bipolar II Disorder

44 registered clinical trials studyying Bipolar II Disorder11 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With
NCT06696755
AbbViePhase 2
RecruitingIndividualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
NCT07213466
Mayo ClinicPhase 4
Enrolling By InvitationAn Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
NCT07217860
Xenon Pharmaceuticals Inc.Phase 3
RecruitingA Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disord
NCT07172516
Xenon Pharmaceuticals Inc.Phase 3
RecruitingClosed-Loop Deep Brain Stimulation for Treatment-Resistant Bipolar Depression
NCT07127913
Andrew KrystalN/A
RecruitingAcceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
NCT06706232
The University of Texas Health Science Center, HoustonPhase 2
CompletedAssessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder
NCT07116694
BioXcel Therapeutics IncPhase 2
Not Yet RecruitingSYNCED - SYNChronized Eating in Bipolar Depression Study
NCT06560957
University of OttawaN/A
RecruitingLHC-CIDI-5 in Hong Kong
NCT06804525
The University of Hong Kong
CompletedStudy of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipo
NCT06605599
AbbViePhase 2
RecruitingLithium Versus Lamotrigine in Bipolar Disorder, Type II
NCT06184581
University Hospital Bispebjerg and FrederiksbergPhase 4
SuspendedCBT for Problematic Impulsive Behaviours in Bipolar Disorder: A Case Series / CBT-PIB
NCT06129500
University of ExeterN/A
TerminatedPhase 2 Clinical Trial of GH001 in Bipolar II Disorder
NCT05839509
GH Research Ireland LimitedPhase 2
UnknownImpact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar Illness
NCT05705063
Stanford UniversityN/A
CompletedDexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III
NCT05658510
BioXcel Therapeutics IncPhase 3
SuspendedBraining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression
NCT05340686
Region StockholmN/A
CompletedMaintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression
NCT05339074
Joshua RosenblatPhase 2
CompletedKetamine for Treatment-Resistant Bipolar Disorder
NCT05004896
Joshua RosenblatPhase 2
RecruitingChildren's Bipolar Network Treatment Trial I
NCT05427123
University of California, Los Angeles
CompletedEfficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine L
NCT05400785
HucircadianN/A
CompletedEvaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder
NCT05340504
Medical University of South CarolinaPhase 2
RecruitingGabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
NCT05064319
Medical University of South CarolinaPhase 2
Active Not RecruitingPsilocybin Therapy for Depression in Bipolar II Disorder
NCT05065294
University of California, San FranciscoPhase 2
UnknownThe Effect of Interpersonal Relationships and Social Rhythm Therapy Individuals With Bipolar Disorder
NCT05420792
Ege UniversityN/A
UnknownNaturalistic Study of Ketamine in the Treatment of Depression
NCT05249309
Hospital de Clinicas de Porto Alegre
UnknownEmotional Proactive Processing in Bipolar Disorder
NCT04561622
University Hospital, Grenoble
WithdrawnA Non-Interventional Pilot Study to Explore the Role of Gut Flora in Bipolar Disorder
NCT04211428
ProgenaBiome
Unknownadd-on Low Dose Memantine in Middle-to-old Aged Bipolar II Disorder Patients
NCT04035798
National Cheng-Kung University HospitalPhase 2 / Phase 3
CompletedTreating Smokers With Mental Illness
NCT03822416
University of MinnesotaPhase 2
CompletedEfficacy of Convulsive Therapies for Bipolar Depression
NCT03641300
Centre for Addiction and Mental HealthN/A
UnknownContinuous Theta Burst Stimulation as an add-on Treatment for Bipolar Depression
NCT03603561
Universiteit AntwerpenN/A
Active Not RecruitingLow Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression
NCT03484494
Mclean HospitalN/A
CompletedGabapentin for Bipolar & Cannabis Use Disorders
NCT03334721
Medical University of South CarolinaPhase 2
CompletedThe BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic
NCT03156504
Mayo ClinicPhase 4
CompletedDifferential Responses to Drugs and Sweet Tastes
NCT03810703
University of ChicagoPhase 1
CompletedEffect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disor
NCT02593643
Sunnybrook Health Sciences CentreEARLY_Phase 1
TerminatedGinger.io Behavioral Health Study
NCT02491307
Community Health Center, Inc.N/A
CompletedStudy of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
NCT01731119
University of North Carolina, Chapel HillPhase 2
CompletedSequential Multiple Assignment Treatment for Bipolar Disorder
NCT01588457
The University of Texas Health Science Center at San AntonioPhase 4
CompletedPrevention of Weight Gain in Early Psychoses
NCT01075295
Centre for Addiction and Mental HealthN/A
CompletedSensoril(Ashwaganhda)for Bipolar Disorder
NCT00761761
University of PittsburghPhase 3
CompletedSeroquel in the Treatment of Dysphoric Hypomania in Bipolar II
NCT00186043
Stanford UniversityPhase 4
CompletedPsychotherapy for Bipolar II Depression, Pilot Study, Phase II
NCT00411463
University of PittsburghPhase 2 / Phase 3
CompletedOpen-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression
NCT00237666
The Medical Research NetworkPhase 4